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Abstract The mouse mdr2 P-glycoprotein (P-gp) and its human MDR3 homologue are present in high concentrations in the canalicular membrane 
of hepatocytes. Mice lacking this protein are unable to secrete phosphatidylcholine (PC) into bile, suggesting that this P-gp is a PC translocator. We 
have tested this in fibroblasts from transgenic mice expressing the MDR3 gene under a vimentin promoter. Transgenic and control fibroblasts were 
incubated with [‘%]choline to label PC. When the labeled cells were incubated with a PC transfer protein and acceptor liposomes, transfer of 
radioactive PC was enhanced in transgenic cells relative to the wild type controls. We conclude that the MDR3 P-glycoprotein s able to promote 
the transfer of PC from the inner to the outer leaflet of the plasma membrane, supporting the idea that this protein functions as a PC flippase. 
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1. Introduction 
Upon selection with a single cytotoxic drug mammalian cells 
can become resistant to a variety of structurally and fimction- 
ally unrelated drugs, a phenomenon called Multidrug Resis- 
tance (MDR). The best known form of MDR is caused by 
(over)expression of P-glycoproteins (P-gps), 140-170 kDa 
transmembrane proteins that actively extrude drugs from the 
cell. Human cells contain only one gene encoding such a pro- 
tein, the MDRl gene, whereas mice have two genes for drug 
pumping P-gps, mdrla and mdrlb (also known as mdr3 and 
mdrl , respectively) (reviewed in [l-3]). 
In addition to these drug-transporting P-gps, mammals also 
contain a P-gp that appears unable to transport drugs [4,5]. 
This P-gp is mainly found in the canalicular membrane of the 
liver [6,7] and is encoded by the MDR3 (also called MDR2) 
gene in humans [8,9] and the highly homologous mdr2 gene in 
mice [4]. 
To find the physiological function of this P-gp, we have 
generated mice with a disruption of the mdr2 gene [lo]. These 
mice are unable to secrete phospholipid into their bile. As 
biliary phospholipid is nearly exclusively PC, this suggested 
that the mdd P-gp is required for the transport of PC through 
the canalicular membrane of the hepatocyte [lo]. 
To get more information on the mechanism of PC transport 
by the mdr2/MDR3 P-gp, we have analyzed the transport of 
newly synthesized PC in mouse fibroblasts expressing the 
human MDR3 gene at a high level. Normal mouse fibroblasts 
do not express the mdr2 gene and these were used as control 
for PC transport in the absence of P-gp. 
*Corresponding author. Fax: (31) (20) 6691383. 
2. Materials and methods 
2.1. Cells and cell culture 
Primary MDR3 transgenic murine ear fibroblast cells were isolated 
from transgenic FVB mice expressing a MDR3 mini gene behind a 
vimentin promoter-enhancer xpression cassette. MDR3 transgenic ell 
line VOlVOl was derived from these cells after immortalization by 
infection with SV40 virus. Control cell line FVB#c was similarly made 
from wild type mice, as described earlier [6]. The cells were cultured in 
Dulbecco’s Modified Eagles Medium (DMEM), supplemented with 
4 mM L-glutamine, penicillin (50 units/ml), streptomycin (5O&ml) and 
10% fetal bovine serum in the presence of 5% CO,. The cells were 
subcultured every 3 to 4 days. 
2.2. Materials 
[methyl-‘4C]choline chloride (55 mCi/mmol) was purchased from 
Amersham (Buckinghamshire, UK). All tissue culture chemicals were 
obtained from Gibco BRL (Bethesda, USA). PC transfer protein 
(PC-TP) was purified from bovine liver according to Kamp and Wirtz 
t111. 
2.3. Preparation of acceptor liposomes 
Liposomes were prepared from egg PC, cholesterol and phosphatidic 
acid (molar ratio = 10 : 10 : 1). The lipids were dried from a chloroform/ 
methanol 2 : 1 (v/v) solution and dispersed in buffer A (140 mM NaCl, 
5 mM KCl, 1.3 mM CaCl,, 1 mM MgCl,, 15 mM glucose, 10 mM 
HEPES, pH 7.4) at a final concentration of 2 mM PC. Liposomes were 
obtained by sonication of the lipid suspension with a Branson sonifier 
at 65 W for 30 min at 0°C. 
2.4. PC transport assay 
The cells were trypsinized and replated in six-wells plates (Costar, 
9 cm2 per well) at a density of 5 x lo5 cells per well and cultured for 
20 h as described above. The medium was removed and the cells were 
washed once with phosphate buffered saline (PBS). 2 ml inositol free 
and choline low Hanks Minimal Essential Medium (HMEM) was 
added, supplemented with 0.4&i [methyl-‘%]choline chloride (55 Mci/ 
mmol). T’he cells were metabolically labeled for 3 h under standard 
growth conditions. Afterwards the medium was removed and the mon- 
olayer was washed twice with buffer A. To the cells 1 ml of buffer A 
with various amounts of PC-TP and with a liposome suspension con- 
taining 200 mu01 PC was added, this is a 15-fold excess compared to 
the estimated amount of PC present in the cells. The cells were incu- 
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bated at 37”C, while shaking gently (approx. 50 rpm). At various time 
points the buffer was removed and the cells were washed once with PBS 
and trypsinized; the PBS used in this washing step did not contain a 
significant amount of radioactivity. Lipids were extracted from both the 
cells and the medium according to Bligh and Dyer [12]. A fraction 
(500 ,ul) of the chloroform phase (1.9 ml) was dried down and the 
radioactivity was determined by liquid scintillation counting, using a 
Packard Tri-Carb 1500 Liquid Scintillation Analyzer. 
2.5. Viability assay 
To determine the viability of the cell lines during the exchange xper- 
iment, cells of both lines were plated in six-wells plates and grown for 
20 h. The monolayer was subsequently washed with PBS and the cells 
were incubated with either DMEM or buffer A for 4 h. Afterwards the 
cells were washed with PBS, trypsinized and the number of viable 
(Trypan blue excluding) cells and non viable cells was determined. 
2.6. Thin layer chromatography 
After extraction of the lipids from the cells, a quarter of the chloro- 
form/methanol phase was evaporated, taken up into 50 ~1 chloroform 
and applied on Silica Gel 60 plates (0.25 mm, Merck). The plates were 
developed twice in chlorofotm/methanol/ammonia (258, w/$/water 
(50:65 :5:4, by volume) and visualized by primuline staining. 
Lipid containing spots were scraped off and counted in 4 ml of Packard 
Ultima Gold liquid scintillation fluid. 
3. Results 
In Fig. 1 the rationale of the exchange assay is schematically 
depicted. The cells incubated with [‘4C]choline will synthesize 
labeled PC in their endoplasmic reticulum (ER). From the ER 
[r4C]PC will be transported to the plasma membrane, either by 
endogenous lipid transfer protein (L-TP) mediated monomeric 
diffusion, inserting the labeled PC into the inner leaflet only, 
or by vesicle flow, delivering the PC to both leaflets. Only the 
labeled PC in the outer leaflet can be transferred to the acceptor 
liposomes in the medium by the exogenous PC-TP (Fig. 1B). 
In cells lacking a PC transporter in the plasma membrane PC 
can only reach the outer leaflet by vesicular transport or by a 
low rate of spontaneous flipping. The presence of a translocator 
(also called flippase) will result in a more rapid appearance of 
labeled PC in the outer leaflet and hence in a more rapid 
labeling of added liposomes in the presence of exogenous 
PC-TP. A transporter mediating vesicular secretion of PC 
would result in labeling of liposomes in the absence of PC-TP. 
To estimate the time needed for efficient labeling of the cell 
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lines, the MDR3 transgenic cell line VOlVOl and the wild type 
FVB#c cells were incubated with labeled choline. Every half 
hour a sample was trypsinized and lipids were extracted. In 
both cell lines substantial amounts of labeled PC were only 
synthesized after 2 h of labeling (Fig. 2). After 3 h, a sufficiently 
high level of PC labeling was reached to start the exchange 
experiment by removing the radioactive choline and adding 
PC-TP and acceptor liposomes. The time scale for the synthesis 
of [‘“C]PC was similar for the FVB#c and VOlVOl lines, but 
in all experiments the amount of radioactive PC produced was 
40 to 50% lower in the VOlVOl cells than in the FVB#c cells 
(Fig. 2). With one-dimensional thin layer chromatography we 
found that the bulk of labeled lipid was [‘4C]PC; only a minor 
fraction was sphingomyeiin and no other labeled lipids were 
detected (results not shown). 
Determination of the viability of the cells in buffer A showed 
that the total number of cells and the percentage of non-viable 
cells did not differ significantly between the two cell lines, nor 
between the two incubation media. The percentage of non- 
viable cells did not exceed 3% in any of the groups (results not 
shown). 
To determine the amount of PC-TP required to exchange PC 
between the cells and the liposomes, [‘“C]PC labeled cells were 
incubated with various amounts of PC-TP for one hour. Figure 
3 shows the percentage of radiolabeled cellular PC transported 
to the liposomes. In the absence of PC-TP, only 2% of the 
labeled PC appears in the liposome fraction and this value was 
not affected by the presence of MDR3 P-glycoprotein in the 
plasma membrane. We attribute this background to vesicula- 
tion of intact membrane or fragmentation of membranes from 
cells in poor condition. The background transfer varied from 
experiment o experiment and dropped to less than 1% in later 
experiments (c.f. Fig. 4). 
Addition of 0.2 mg PC-TP per ml incubation medium re- 
sulted in a substantial increase in the labeled PC appearing in 
the liposome fraction, but this only occurred in the MDR3 
transgenic VOlVOl cells, not in the FVB#c cells (Fig. 3). In- 
creasing the PC-TP concentration to 0.7 mg/ml gave a small 
further increase of label transfer (Fig. 3). Hence, we settled for 
a concentration of 0.2 mg/ml. Note that the acceptor liposomes 
are in large excess in these experiments. The rate of back ex- 
change of labeled PC to the cells is therefore negligible. 
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Fig. 1. Schematic representation of the [‘C]PC exchange assay that was used and the hypothetical role of MDR3 in this process. A, incorporation 
of [‘4C]choline labels PC (black symbols) in the endoplasmic reticulum (ER) and transport of labeled PC from the ER to the plasma membrane (PM) 
either by monomeric diffusion (top), e.g. by PC-TP, inserting labeled PC in the inner leaflet only, or by vesicle flow (bottom), delivering PC to both 
leaflets. B, flipping of labeled PC to the outer leaflet in the presence of MDR3 and exchange of labeled PC by PC-TP from the outer Ieatlet o liposomes 
in the medium. In the absence of MDR3 only the labeled PC inserted directly into the outer leaflet by vesicle flow can be transferred to the liposomes. 
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Fig. 2. Time course of the synthesis of radiolabeled PC from [methyl- 
“C]choline in the murine fibroblast lines FVB#c (open circles) and 
VOlVOl (closed circles). 
The time course of the appearance of radiolabeled PC in the 
acceptor liposomes is shown in Fig. 4. To correct for the aspeci- 
fit PC release, a sample without PC-TP was assayed for each 
time point and for both cell lines. The resulting curves show 
that PC-TP dependent PC exchange occurs in both cell lines, 
but in the MDR3 transgenic ells the PC exchange starts earlier 
and runs at a higher rate. The unusual biphasic time course of 
label transfer from the MDR3 transgenic ells can be explained 
by considering the two intracellular routes known to contrib- 
ute to the labeling of the plasma membrane in other cells 
[ 13-151, i.e. fast transport by cytosolic L-TP and slow transport 
by intracellular vesicles. Transport by L-TP delivers PC into 
the inner leaflet of the plasma membrane. We postulate that this 
is the main route of PC transport in the labeling period of our 
cells. This labeled PC is not available for transfer to the accep- 
tor liposomes unless it can be flipped to the outer leaflet. Hence 
the large difference between control cells and the MDR3 trans- 
genie cells after 60 min in Fig. 4. Vesicular transport is slow and 
delivers labeled PC to both leaflets of the plasma membrane. 
This makes an increasing contribution to the PC available in 
the outer leaflet of both the control cells and the MDR3 trans- 
genie cells, explaining the increased label transfer to acceptor 
liposomes between 120 and 240 min in Fig. 4. 
4. Discussion 
Our results show that the presence of MDR3 P-gp has a 
profound influence on the distribution of newly synthesized PC 
in the plasma membrane of murine fibroblasts. The redistribu- 
tion is not accompanied by detectable secretion of PC. We 
therefore conclude that this P-gp is a PC flippase, that can flip 
a PC molecule from one lipid leaflet of a bilayer to the other. 
As this conclusion is based on indirect experiments, possible 
confounding artifacts should be considered. 
All available evidence indicates that extra-cellular PC-TP can 
only interact with PC in the outer leaflet of the plasma mem- 
brane of intact cells [16]. The PC-TP dependent transfer of 
radioactive PC to acceptor liposomes in our experiments must 
therefore be derived from the outer leaflet of the fibroblast 
plasma membrane. It is unlikely that the plasma membrane of 
the MDR3 transgenic cells is more rapidly labeled than that of 
the control cells. The labeling kinetics of both cell lines are 
similar and (for unknown reasons) the MDR3 cells incorporate 
even less label than control cells (Fig. 2). Since both cell lines 
have the same genetic background, it is unlikely that they differ 
with respect o the rate of PC delivery to the plasma membrane. 
The only remaining stage of PC transport to the outer leaflet 
is the direct transport of PC over the plasma membrane. Be- 
cause the MDR3 P-gp is localized in the plasma membrane in 
the VOlVOl cells [6], we may conclude that MDR3 P-gp must 
promote this translocation process to account for the increased 
transfer of newly synthesized PC to external iposomes from the 
v01v01 cells. 
Up to 60 min after the start of the exchange xperiment all 
labeled PC that reaches the plasma membrane of both cell lines 
must have been inserted into the inner leaflet by means of 
intracellular L-TP, since the outer leaflet of the wild type cells 
does not yet contain labeled PC exchangeable by PC-TP (Fig. 
4). The rate of transfer catalyzed by MDR3 P-gp is high: be- 
tween 15 and 60 min exchange time (Fig. 4), approximately 3% 
of the total labeled PC is transferred to acceptor liposomes. The 
plasma membrane of murine fibroblast cell line LM contains 
approximately 40% of the total cellular PC [17-191. The PC 
distribution in our cells probably will not be very different, thus 
almost 8% of the plasma membrane PC must have been flipped 
by the MDR3 P-gp in the period between the start of labeling 
and the 60 min sample in Fig. 4. Only a minimal imbalance 
between the leaflets of the membrane bilayers is permissible. 
We therefore infer that there must be considerable back-flip- 
ping of the PC from the outer leaflet to the inner leaflet in cells 
containing the MDR3 P-gp. This remains to be verified. 
After 120 min, the first labeled PC appears in the outer leaflet 
of the FVB#c control cells (Fig. 4). This may be the result of 
vesicle mediated PC delivery to the plasma membrane, inserting 
labeled PC into the outer leaflet by vesicle fusion. It takes 2 to 
3 hours for the postulated vesicular PC to reach the plasma 
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Fig. 3. Percentage oflabeled PC that can be exchanged from the outer 
leaflet of the membrane to the liposomes in the medium by various 
amounts of PC-TP. After labeling with [‘4C]choline for three hours, the 
cells were incubated with PC-TP for one hour. Wild type PVB#c cells, 
open circles; MDR3 transgenic VOlVOl cells, closed circles. All values 
are based on two independent experiments. The range is shown by a 
vertical bar. 
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Fig. 4. Time course of the transfer of labeled PC to liposomes with or 
without PC-TP. Wild type FVB#c cells, open symbols; MDR3 trans- 
genie VOlVOl cells, closed symbols. No PC-TP added, squares; 0.2 
mg/ml PC-TP added, circles. All values are based on two independent 
measurements. The range is shown by a vertical bar. 
membrane in our fibroblasts. This is longer than the 3&60 min 
observed in other cell types [13-151. This could be due to differ- 
ences in metabolism or handling of the cells. 
The PC-TP mediated transport from VOlVOl cells to li- 
posomes reaches a plateau between 60 and 120 minutes of 
exchange (Fig. 4), suggesting a decrease in the rate of delivery 
of labeled PC to the plasma membrane. This is not unreasona- 
ble if intracellular transport by L-TP occurs shortly after PC 
synthesis. The high extent of exchange that is observed between 
t = 0 and t = 60 min is not only the result of [‘“C]PC delivered 
in this period, but also of labeled PC that accumulated in the 
outer leaflet between t = -60 and t = 0. 
After this work was completed, Ruetz and Gros [20] reported 
studies on the activity of the murine mdr2 Pgp in yeast inside- 
out secretory vesicles. They found that these vesicles accumu- 
late a relatively water-soluble, fluorescent PC analog and that 
the accumulation was dependent on ATP hydrolysis. Although 
PC analogs and natural PC may behave very differently under 
some conditions [2 11, the results of Ruetz and Gros [ 181 support 
the idea that the MDR3/mdr2 P-gp is a PC translocator. They 
have shown that this P-gp can take its PC analog from the 
cytoplasmic leaflet [20]. We find that it donates its PC to the 
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ectoplasmic leaflet. In combination these results are consistent 
with the hypothesis that human MDR3 P-gp and its murine 
homologue mdr2 P-gp are flippases that transport PC from the 
inner to the outer leaflet of the membrane they are residing in. 
Acknowledgements: We are most grateful to J. Westerman (CLBE, 
Utrecht University) for the purification of PC-TP from bovine liver. We 
would like to thank Drs. Ronald Oude Elferink, Bert Groen, Guido 
Zaman and Lisette Eijdems for helpful discussions and critical reading 
of the manuscript. This work was supported by Grant NKI 9241 of 
the Dutch Cancer Society to P.B. 
References 
PI 
PI 
[31 
141 
[51 
PI 
PI 
191 
[W 
[ill 
u51 
WI 
v71 
WI 
[I91 
PO1 
t211 
Endicott, J.A. and Ling, V. (1989) Annu. Rev. B&hem. 58, 137- 
171. 
Schinkel, A.H. and Borst, P. (1991) Semi,. Cancer Biol. 2, 213- 
226. 
Gottesman, M.M. and Pastan, I. (1993) Annu. Rev. Biochem. 62, 
385-427. 
Gros, P., Raymond, M., Bell, J. and Housman, D. (1988) Mol. 
Cell. Biol. 8, 277&2778. 
Schinkel, A.H., Roelofs, M.E.M. and Borst, P. (1991) Cancer Res. 
51,2628-2635. 
Smit, J.J.M., Schinkel, A.H., Mol, C.A.A.M., Majoor, D., Mooi, 
W.J., Jongsma, A.P.M., Lincke, C.R. and Borst, P. (1994) Lab. 
Invest., in press. 
Buschman, E., Arc=eci, R.J., Croop, J.M., Ch, M., Arias, I.M., 
Housman, D.E. and Gros, P. (1992) J. Biol. Chem. 267, 18093- 
18099. 
van der Bliek, A.M., ten Houte de Lange, T., Kooiman, P.M., van 
der Velde-Koerts, T. and Borst, P. (1987) EMBO I. 6, 3325-3331. 
van der Bliek, A.M., Kooiman, P.M., Schneider, C. and Borst, P. 
(1988) Gene 71, 401411. 
Smit, J.J.M., Schinkel, A.H., Oude Elferink, R.P.J., Groen, A.K., 
Wagenaar, E., van Deemter, L., Mol, C.A.A.M., Ottenhof, R., van 
der Lugt, N.M.T., van Roon, M.A., van der Valk, M.A., Offer- 
haus, G.J.A., Berm, A.J.M. and Borst, P. (1993) Cell 75,451462. 
Kamp, H.H. and Wirtz, K.W.A. (1974) Methods Enzymol. 32, 
140-146. 
Bligh, E.G. and Dyer, W.J. (1959) Can. J. Biochem. Phys. 37,911. 
Kaplan, M.R. and Simoni, R.D. (1985) J. Cell Biol. 101,441-445. 
Mills, J.T., Furlong, S.T. and Dawidowicz, E.A. (1984) Proc. Natl. 
Acad. Sci. USA 81, 1385-1388. 
DeSilva, N.S. and Siu, C.H. (1981) J. Biol. Chem. 256,5846-5850. 
Wirtz, K.W.A. (1991) Annu. Rev. Biochem. 60, 73-99. 
Devaux, P.F. (1991) Biochemistry 30, 1163-1173. 
Esko, J.D., Gilmore, J.R. and Glaser, M. (1977) Biochemistry 16, 
1881-1890. 
Sandra, A. and Pagano, R.E. (1978) Biochemistry 17, 322-338. 
Rue@ S. and Gros, P (1994) Cell 77, 1071-1081. 
Roelofsen, B. and Op den Kamp, J.A.F. (1994) Curr. Topics 
Membr. 40, 746. 
